Drug Shortage Report for CERETEC

Last updated on 2024-08-22 History
Report ID 232987
Drug Identification Number 02329034
Brand name CERETEC
Common or Proper name Kit for the Preparation of Technetium-99m Exametazime Injection
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) EXAMETAZIME
Strength(s) 0.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 vial kit
ATC code V09HA
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-08-02
Actual start date 2024-08-06
Estimated end date 2024-08-23
Actual end date 2024-08-21
Shortage status Resolved
Updated date 2024-08-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2024-08-22 English Compare
v26 2024-08-21 French Compare
v25 2024-08-21 English Compare
v24 2024-08-21 French Compare
v23 2024-08-21 English Compare
v22 2024-08-09 French Compare
v21 2024-08-09 English Compare
v20 2024-08-07 French Compare
v19 2024-08-07 English Compare
v18 2024-08-07 English Compare
v17 2024-08-06 French Compare
v16 2024-08-06 English Compare
v15 2024-08-03 English Compare
v14 2024-07-31 French Compare
v13 2024-07-31 English Compare
v12 2024-07-31 English Compare
v11 2024-07-26 French Compare
v10 2024-07-26 English Compare
v9 2024-07-24 French Compare
v8 2024-07-24 English Compare

Showing 1 to 20 of 27